Abstract
The mechanism of cholestasis (decreased bile flow) induced by taurolithocholate in the isolated perfused hamster liver was investigated. Taurocholate was infused to maintain bile acid output, and sulfobromophthalein (BSP) was administered to establish a BSP transport maximum in bile. The effects of taurolithocholate on bile flow and on the biliary secretion of BSP and bile acid anions were determined.A significant dose-response correlation was found between taurolithocholate and the degree of cholestasis. No significant hepatic morphologic alterations were observed. At low doses, cholestasis was reversible. A multiple regression equation was developed to validate the steroid dehydrogenase determination of total bile acids in bile that contained BSP. During cholestasis, output of bile acid was maintained by a significantly increased concentration of bile acid. Hepatic removal rate and transport maximum of BSP were significantly decreased, whereas BSP concentration, conjugation, and hepatic content were unaffected. The concentrating capacity for BSP in bile appeared to be the rate-limiting factor in BSP transport. Individual bile acids were determined by gas-liquid chromatography. Of the injected taurolithocholate, 40-50% was recovered in bile as lithocholic acid, 30% was converted to chenodeoxycholic acid, and only traces of lithocholic acid were detected in the perfusate after 4 hr. Cholic and chenodeoxycholic acids comprised 75-89%, and lithocholic acid comprised 11-25% of bile acids in bile after taurolithocholate injection; only traces of deoxycholic acid were seen. Small amounts of taurolithocholate sulfate were detected in bile by thinlayer chromatography. The outputs of sodium and potassium in bile were significantly diminished during cholestasis.A substantial fraction (75%) of basal bile flow in the isolated hamster liver was estimated to be independent of bile acid secretion. Cholestasis occurred after taurolithocholate, whereas bile acid secretion was maintained. The results indicate that the most likely mechanism for acute cholestasis induced by taurolithocholate in isolated hamster liver was interference with the bile acid-independent fraction of canalicular or ductular bile flow or both.
MeSH Terms
Animals
Bile/analysis,metabolism
Bile Acids and Salts/administration & dosage,analysis,metabolism,toxicity
Bile Ducts, Intrahepatic/drug effects
Cholestasis/chemically induced
Chromatography, Gas
Chromatography, Thin Layer
Cricetinae
Depression, Chemical
Female
In Vitro Techniques
Perfusion
Rheology
Sulfobromophthalein/blood,metabolism
Taurine/toxicity
Chemicals
Bile Acids and Salts
Sulfobromophthalein
Taurine
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
King J E
Schoenfield L J
References (27)
27 references, click to expand
-
Isolated fecal microorganisms capable of 7-alpha-dehydroxylating bile acids.
J Exp Med. 1966 Feb 1;123(2):413-32
PMID: 5325994
-
Duodenal drainage of sulfobromophthalein (BSP) in hepatobiliary disease.
Gastroenterology. 1966 Jul;51(1):59-64
PMID: 5939343
-
Identification of bile acids and neutral sterols in guinea pig bile. Bile acids and steroids 163.
Acta Chem Scand. 1966;20(5):1297-303
PMID: 5961755
-
Detergent properties of bile salts: correlation with physiological function.
Annu Rev Med. 1967;18:333-76
PMID: 5337530
-
Intrahepatic cholestasis: a functional approach to pathogenesis.
Gastroenterology. 1967 Jul;53(1):171-5
PMID: 6028794
-
Canalicular bile production in dogs.
Am J Physiol. 1968 Apr;214(4):866-74
PMID: 5642950
-
Effect of sodium taurolithocholate on bile flow and bile acid exeretion.
J Clin Invest. 1968 May;47(5):1002-14
PMID: 5645847
-
Cholestasis.
Annu Rev Med. 1968;19:39-56
PMID: 4871695
-
Solubility of bile salts.
Nature. 1969 Jan 18;221(5177):265-7
PMID: 5763081
-
The effect of estrogen on bile formation in the rat.
J Clin Invest. 1969 Apr;48(4):654-63
PMID: 5774104
-
[Biliary secretion of rabbit: evidence in favor of important fraction independent of bile salts].
Rev Fr Etud Clin Biol. 1969 Feb;14(2):144-50
PMID: 5792497
-
Cholestasis is the result of hypoactive hypertrophic smooth endoplasmic reticulum in the hepatocyte.
Lancet. 1969 Aug 16;2(7616):355-9
PMID: 4183978
-
Maximal biliary excretion of sulfobromophthalein sodium in sheep.
Am J Dig Dis. 1970 Jan;15(1):37-47
PMID: 5410864
-
The effect of sodium taurocholate on the hepatic metabolism of sulfobromophthalein sodium (BSP). The role of bile flow.
J Clin Invest. 1970 Feb;49(2):206-15
PMID: 5411780
-
Bile secretion in isolated hamster liver.
J Appl Physiol. 1970 Apr;28(4):495-500
PMID: 5437440
-
Hydrocortisone choleresis in the dog.
J Clin Invest. 1970 Sep;49(9):1714-23
PMID: 5449708
-
Mechanism of phenobarbital-induced hypercholeresis in the rat.
Am J Physiol. 1970 Sep;219(3):809-13
PMID: 5450891
-
Canalicular bile flow and bile secretory pressure. Evidence for a non-bile salt dependent fraction in the isolated perfused rat liver.
Gastroenterology. 1970 Dec;59(6):853-9
PMID: 5486271
-
Pathophysiology of cholestasis.
Hum Pathol. 1970 Mar;1(1):1-24
PMID: 4940286
-
Isolated rat liver preparation; bile production and other basic properties.
Proc Soc Exp Biol Med. 1951 Oct;78(1):174-81
PMID: 14891958
-
Studies in the bile acids. 2. The non-ketonic acids of human bile.
Biochem J. 1953 Sep;55(2):292-4
PMID: 13093679
-
Metabolism of sulfobromophthalein sodium (BSP) in dog and man.
Proc Soc Exp Biol Med. 1959 Jan;100(1):174-9
PMID: 13634075
-
The relationship between taurocholate secretion rate and bile production in the unanesthetized dog during cholinergic blockade and during secretin administration.
J Clin Invest. 1962 May;41:1152-62
PMID: 14488578
-
INHIBITORY ASPECTS OF BILE SECRETION.
Nature. 1963 Dec 21;200:1172-6
PMID: 14089899
-
STUDIES OF SULFOBROMOPHTHALEIN SODIUM (BSP) METABOLISM IN MAN. 3. DEMONSTRATION OF A TRANSPORT MAXIMUM (TM) FOR BILIARY EXCRETION OF BSP.
J Clin Invest. 1964 Jul;43:1424-32
PMID: 14192523
-
Enzymic analysis of steroid hormones.
Methods Biochem Anal. 1960;8:119-43
PMID: 13836707
-
Biliary transport and hepatic storage of sulfobromophthalein sodium in the unanesthetized dog, in normal man, and in patients with hepatic disease.
J Clin Invest. 1960 Jul;39:1131-44
PMID: 13844286